Minneapolis, MN 5/3/11—Techne has acquired Tocris, a UK-based supplier of reagents for nonclinical life science research, for £75 million ($124 million = £0.60 = $1) in cash. In 2010, Tocris generated revenues of £11.7 million ($18.2 million = £0.64 = $1), EBITDA of £7.4 million ($11.4 million) and an EBITDA margin of approximately 63%. Techne stated that Tocris’s chemically based compounds will complement the biologically active reagents offered by its R&D Systems and R&D Systems Europe subsidiaries. “The acquisition will enhance and supplement the depth and breadth of R&D Systems’ product offering and will augment our ability to serve research scientists, as well as leverage our marketing, sales and distribution capabilities with this important product class,” stated Techne President and CEO Tom Oland. The acquisition is expected to increase Techne’s fourth-quarter fiscal 2011 revenues by approximately $3.5 million. It is anticipated to be slightly dilutive to fourth-quarter fiscal 2011 and fiscal 2012 net earnings. Tocris’s management and employees will remain at the company’s Bristol, UK, headquarters.